Publications by: Howard L. Parnes

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 3.

Hoque, Ashraful, Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K.V., vanBokhoven, Adrie, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Ambrosone, Christine B., and Thompson, Ian (2015) Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology, 85 (3). pp. 616-620.

Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Chen, Xiaohong, Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Tangen, Catherine M., Chu, Lisa, Parnes, Howard L., Schenk, Jeannette M., Reichardt, Juergen K.V., Thompson, Ian M., and Figg, William D. (2015) Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PLoS One, 10 (5).

Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen, Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L,, Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., and Hoque, Ashraful (2011) Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer causes and control, 22 (8). pp. 1121-1131.

This list was generated on Sat Oct 21 18:42:27 2017 AEST.